<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Drug Resist</journal-id><journal-id journal-id-type="iso-abbrev">Infect Drug Resist</journal-id><journal-id journal-id-type="publisher-id">idr</journal-id><journal-title-group><journal-title>Infection and Drug Resistance</journal-title></journal-title-group><issn pub-type="epub">1178-6973</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9440705</article-id><article-id pub-id-type="publisher-id">369339</article-id><article-id pub-id-type="doi">10.2147/IDR.S369339</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Bioprospecting by Phage Display of Mimetic Peptides of <italic toggle="yes">Chlamydia trachomatis</italic> for Use in Laboratory Diagnosis</article-title><alt-title alt-title-type="running-authors">Freitas et al</alt-title><alt-title alt-title-type="running-title">Freitas et al</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>de Freitas</surname><given-names>Larissa Silva</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ft0002" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2014-2770</contrib-id><name><surname>Queiroz</surname><given-names>Maria Alice Freitas</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ft0002" ref-type="author-notes">*</xref><xref rid="an0001" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4571-4715</contrib-id><name><surname>Machado</surname><given-names>Luiz Fernando Almeida</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1135-6507</contrib-id><name><surname>Vallinoto</surname><given-names>Antonio Carlos Ros&#x000e1;rio</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ishak</surname><given-names>Marlu&#x000ed;sa de Oliveira Guimar&#x000e3;es</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Fabiana de Almeida Ara&#x000fa;jo</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Goulart</surname><given-names>Luiz Ricardo</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ft0001" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4741-6201</contrib-id><name><surname>Ishak</surname><given-names>Ricardo</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><aff id="aff0001"><label>1</label><institution>Laboratory of Virology, Biological Sciences Institute, Federal University of Par&#x000e1;</institution>, <addr-line>Bel&#x000e9;m</addr-line>, <addr-line>Par&#x000e1;</addr-line>, <country>Brazil</country></aff><aff id="aff0002"><label>2</label><institution>Laboratory of Nanobiotechnology, Genetics and Biochemistry Institute, Federal University of Uberl&#x000e2;ndia</institution>, <addr-line>Uberl&#x000e2;ndia</addr-line>, <addr-line>Minas Gerais</addr-line>, <country>Brazil</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Maria Alice Freitas Queiroz, <institution>Laboratory of Virology, Biological Sciences Institute, Federal University of Par&#x000e1;</institution>, <addr-line>Bel&#x000e9;m</addr-line>, <addr-line>Par&#x000e1;</addr-line>, <country>Brazil</country>, <phone>Tel +55 91 3201-7587</phone>, Email alicefarma@hotmail.com</corresp><fn id="ft0001"><label>&#x02020;</label><p>Luiz Ricardo Goulart passed away on 24/10/2021</p></fn><fn id="ft0002"><label>*</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date pub-type="epub"><day>30</day><month>8</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>15</volume><fpage>4935</fpage><lpage>4945</lpage><history><date date-type="received"><day>21</day><month>4</month><year>2022</year></date><date date-type="accepted"><day>15</day><month>6</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 Freitas et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Freitas et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><sec id="s2001"><title>Background</title><p><italic toggle="yes">Chlamydia trachomatis</italic> infection is a major public health problem and the most common sexually transmitted infection in the world. Although highly prevalent, 70% to 80% of cases are asymptomatic and undiagnosed.</p></sec><sec id="s2002"><title>Purpose</title><p>To overcome some limitations in terms of rapid diagnosis, phage display technology was used to bioprospect peptide mimetics of <italic toggle="yes">C. trachomatis</italic> immunoreactive and immunogenic antigens to be selected for the production of synthetic peptides.</p></sec><sec id="s2003"><title>Methods</title><p>Initially, IgG from 22 individuals with <italic toggle="yes">C. trachomatis</italic> and 30 negative controls was coupled to G protein magnetic beads. The phage display technique consisted of biopanning, genetic sequencing, bioinformatics analysis and phage ELISA.</p></sec><sec id="s2004"><title>Results</title><p>Clones G1, H5, C6 and H7 were selected for testing with individual samples positive and negative for <italic toggle="yes">C. trachomatis</italic>. Reactions were statistically significant (p &#x0003c; 0.05), with a sensitivity of 90.91, a specificity of 54.55, and AUC values &#x0003e;0.8. One-dimensional analysis with <italic toggle="yes">C. trachomatis</italic> components indicated that the G1 clone aligned with cell wall-associated hydrolase domain-containing protein, the H5 clone aligned with glycerol-3-phosphate acyltransferase PlsX protein, the C6 clone aligned with a transposase and inactivated derivatives, and the H7 clone aligned with GTP-binding protein. Molecular modeling and three-dimensional analysis indicated the best fit of the four clones with a protein known as chlamydial protease/proteasome-like activity factor (CPAF), an important virulence factor of the bacterium.</p></sec><sec id="s2005"><title>Conclusion</title><p>The peptides produced by phage display are related to the metabolic pathways of <italic toggle="yes">C. trachomatis</italic>, indicating that they can be used to understand the pathogenesis of the infection. Because of their high sensitivity and AUC values, the peptides present considerable potential for use in platforms for screening <italic toggle="yes">C. trachomatis</italic> infections.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd><italic toggle="yes">C. trachomatis</italic></kwd><kwd>phage display</kwd><kwd>mimetic peptides</kwd><kwd>CPAF</kwd><kwd>screening tests</kwd></kwd-group><funding-group><award-group><funding-source>
<institution-wrap><institution>the Pr&#x000f3;-Amaz&#x000f4;nia/CAPES program</institution></institution-wrap>
</funding-source></award-group><award-group><funding-source>
<institution-wrap><institution>the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico &#x02013; CNPq) and to the Universidade Federal do Para for the generous funding</institution></institution-wrap>
</funding-source></award-group><funding-statement>The project was generously funded by the Pr&#x000f3;-Amaz&#x000f4;nia/CAPES program (RI, 23038000732/2013-09). ACRV (#302935/2021-5), LFAM (#314209/2021-2) and RI (#312979/2018-5) are supported by research grants from and grateful to the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico &#x02013; CNPq) and to the Universidade Federal do Para for the generous funding (PROPESP/PAPQ/2021).</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="2"/><ref-count count="61"/><page-count count="11"/></counts></article-meta></front><body><sec sec-type="intro" id="s0001"><title>Introduction</title><p><italic toggle="yes">Chlamydia trachomatis</italic>, a causative agent of serious diseases such as urethritis, venereal lymphogranuloma and trachoma,<xref rid="cit0001" ref-type="bibr">1&#x02013;6</xref> may present in its development cycle structures called elementary bodies (extracellular and infective) and reticular bodies.<xref rid="cit0007" ref-type="bibr">7</xref>,<xref rid="cit0008" ref-type="bibr">8</xref>
<italic toggle="yes">C. trachomatis</italic> has a trilaminar membrane containing liposaccharides and proteins<xref rid="cit0009" ref-type="bibr">9</xref>,<xref rid="cit0010" ref-type="bibr">10</xref> and antigens common to the genus <italic toggle="yes">Chlamydia</italic> and species- and serotype-specific antigens.<xref rid="cit0011" ref-type="bibr">11</xref> These antigens include the major outer membrane protein (MOMP), which is related to the pathogenesis of infection and laboratory diagnosis and allows the definition of 19 antigenic variants of the species.<xref rid="cit0012" ref-type="bibr">12&#x02013;17</xref></p><p>The laboratory diagnosis of <italic toggle="yes">C. trachomatis</italic> can be performed by traditional methods ranging from isolation in cell culture to nucleic acid detection; however, technical difficulties remain, but once overcome, the sensitivity and specificity standards of diagnostic methods may be improved.<xref rid="cit0018" ref-type="bibr">18&#x02013;20</xref> In Brazil, the gold standard for characterizing the infection is isolation of <italic toggle="yes">C. trachomatis</italic> in cell cultures, a methodology that is rarely used (sensitivity of 70&#x02013;90%), as it requires specialized personnel, a specific laboratory and strict requirements for collection, transportation and handling of the samples.<xref rid="cit0021" ref-type="bibr">21&#x02013;24</xref></p><p>Direct immunofluorescence is another technique used, but readings of the results under the immunofluorescence microscope are often difficult and subjective. Molecular methods using PCR are sensitive and specific, but the technique is not widely available for small- and medium-size laboratories, as it requires specialized personnel and is costly.<xref rid="cit0021" ref-type="bibr">21</xref> Serological methods for antibody detection have been available for many decades, but cross reactivity with other species of <italic toggle="yes">Chlamydia</italic> is common.<xref rid="cit0025" ref-type="bibr">25</xref>,<xref rid="cit0026" ref-type="bibr">26</xref> The use of microimmunofluorescence to discriminate serological reactions according to serotypes of <italic toggle="yes">C. trachomatis</italic> and <italic toggle="yes">C. pneumoniae</italic> was a gold standard, but reagents are no longer readily available.<xref rid="cit0027" ref-type="bibr">27</xref>,<xref rid="cit0028" ref-type="bibr">28</xref> These are the main reasons why we must seek new, rapid and more precise diagnostic platforms, which are continuously being investigated.<xref rid="cit0029" ref-type="bibr">29</xref>,<xref rid="cit0030" ref-type="bibr">30</xref></p><p>The phage display method is a fast, simple, accessible and relatively inexpensive technology that can select high-affinity ligands and define relevant mimetic peptides that can be used in diagnostic assays and vaccine systems.<xref rid="cit0031" ref-type="bibr">31&#x02013;35</xref> The technique is an important low-cost approach for the identification of peptides that can be used in different health areas; the results can be quickly defined and readily used for the diagnosis of several human infectious diseases.<xref rid="cit0035" ref-type="bibr">35&#x02013;39</xref> The identification of mimetic peptides of <italic toggle="yes">C. trachomatis</italic> may be the basis for future methods for rapid diagnosis (point of care), which could be used in medical offices within local infectious disease support clinics, home care testing and screening tests for epidemiological studies, among others.</p><p>The objective of this study was to bioprospect, identify and characterize mimetic peptides of <italic toggle="yes">C. trachomatis</italic> antigens for use in serological diagnostic platforms.</p></sec><sec id="s0002"><title>Materials and Methods</title><sec id="s0002-s2001"><title>Sample Collection and Processing</title><p>Blood samples from women older than 18 years living in the state of Par&#x000e1;, Brazil, who spontaneously sought cervical cancer prevention services at the Laboratory of Cytopathology, Biological Sciences Institute (Instituto de Ci&#x000ea;ncias Biol&#x000f3;gicas - ICB) of Federal University of Par&#x000e1; (Universidade Federal do Par&#x000e1; - UFPA) were analyzed. The blood samples were collected into a vacuum collection system containing EDTA as an anticoagulant and then transported to the Laboratory of Virology (ICB-UFPA), where they were centrifuged at 3500 rpm for 15 minutes to separate the plasma and cellular components, which were then frozen at &#x02212;80 &#x000b0;C until use.</p><p>Two commercial immunoenzymatic ELISA tests (SERION ELISA classic) for the detection of antibodies (anti-<italic toggle="yes">Chlamydia trachomatis</italic> IgG and anti-<italic toggle="yes">Chlamydia pneumoniae</italic> IgG) were used to characterize the samples into three groups: 30 samples negative for <italic toggle="yes">Chlamydia</italic> (negative control, NC), 22 samples positive only for <italic toggle="yes">C. trachomatis</italic> (positive control, CT+) and 30 samples positive only for <italic toggle="yes">C. pneumoniae</italic> (CP+). Samples were selected from patients with a cytological diagnosis (Papanicolaou smears) suggestive of <italic toggle="yes">C. trachomatis</italic>, confirmed by PCR, and positive for IgG anti-<italic toggle="yes">C. trachomatis</italic>.</p></sec><sec id="s0002-s2002"><title>Phage Display</title><p>The phage display technique followed a previously described method.<xref rid="cit0040" ref-type="bibr">40</xref> First, the IgG antibodies of each group (NC, CP+ and CT+) were bound to magnetic beads coupled with G protein (Dynabeads&#x02013;Invitrogen). Biopanning consisted of three selection cycles (three rounds), and in each cycle, the phages were subjected to two negative selection steps (NC IgG, CP+ IgG) and one selection step with the target of interest (CT+ IgG). A library of random peptides fused to the N-terminal region of Protein III (pIII) of phage M13 (Ph.D.-C7C; New England BioLabs<sup>&#x000ae;</sup> Inc.) was added to the NC IgG pool. After incubation at 37 &#x000b0;C, the supernatant was transferred to the tube containing the CP+ IgG pool (both used for negative selection) and subsequently to the CP+ IgG pool (positive selection). The incubation performed at each step lasted 30 minutes. The phages coupled to the antibodies bound to the magnetic microspheres of the positive selections were recovered by acid elution and subjected to amplification, titration, supernatant production, DNA extraction and DNA sequencing.</p><sec id="s0002-s2002-s3001"><title>Phage Amplification</title><p>Amplification consisted of phage multiplication and was performed in Luria-Bertani culture medium (LB medium) supplemented with tetracycline and <italic toggle="yes">E. coli</italic> (ER2738 from New England BioLabs<sup>&#x000ae;</sup> Inc.). The next day, the material was centrifuged at 10,000 rpm for 10 minutes at 4 &#x000b0;C and washed with sterile 1x PBS. Then, the suspension containing phage was incubated in PEG/NaCl, and finally, the isolated phages were suspended in 1x PBS.</p></sec><sec id="s0002-s2002-s3002"><title>Titration</title><p>Titration was performed to determine the input and output of viral particles during the biopanning cycles. Nonamplified eluate (diluted from 10<sup>&#x02212;1</sup> to 10<sup>&#x02212;5</sup>) and amplified eluate (diluted from 10<sup>&#x02212;1</sup> to 10<sup>&#x02212;12</sup>) were used, with only the last three dilutions of each eluate in the titration being used. <italic toggle="yes">E. coli</italic> ER2738 was grown in LB medium, and upon reaching the mid-log phase (OD<sub>600</sub>~0.5), dilutions containing the phages were added and cultured on LB agar plates containing tetracycline and IPTG/Xgal (isopropyl-beta-D thiogalactopyranoside/5-bromo-4-chloro-3-indolyl-&#x003b1;-D-galactoside). Plating was performed on Top agar, and the plates were incubated at 37 &#x000b0;C for 24 hours.</p></sec><sec id="s0002-s2002-s3003"><title>Phage Supernatant Production</title><p>Phage supernatants were produced by amplifying the phages in LB medium (with tetracycline) containing <italic toggle="yes">E. coli</italic> ER2738 in deepwell plates, which were incubated under stirring on a shaker at 220 rpm in an oven at 37 &#x000b0;C for 4&#x02013;5 hours. A different clone of phage grown in Petri dishes was added to each well. The phage supernatant was used to back up the clones and extract DNA from the phages.</p></sec><sec id="s0002-s2002-s3004"><title>DNA Extraction</title><p>DNA extraction from phages was performed using iodide buffer. The procedure consisted of cell lysis, protein precipitation, DNA precipitation and DNA hydration. Then, the presence of single-stranded DNA was verified in a 0.8% agarose gel containing HydraGreen&#x02122; Safe DNA Stain 20,000X (Hydragene, Piscataway, NJ, USA) by visual comparison with standard M13mp18 purified single-stranded DNA (New England Biolabs, Ipswich, Massachusetts, USA).</p></sec><sec id="s0002-s2002-s3005"><title>Sequencing Reaction</title><p>For the nucleotide sequencing reaction, template DNA, primer-96 gIII (5&#x02019;-OH CCC TCA TAG TTA GCG TAA CG-3&#x02019; - Biolabs) and Premix (DYEnamic ET Dye Terminator Cycle Kit; Amersham Biosciences, Amersham, UK) were used. The reaction was performed in a thermocycler (Kasvi, S&#x000e3;o Jos&#x000e9; dos Pinhais, PR, Brazil). The sequenced DNA was precipitated and resuspended in dilution buffer (DYEnamic ET Dye Terminator Cycle Kit &#x02013; Amersham Biosciences) and read in an ABI PRISM<sup>TM</sup> 3130 Genetic Analyzer (Applied Biosystems, Massachusetts, USA).</p></sec><sec id="s0002-s2002-s3006"><title>Bioinformatics Data Analysis</title><p>The DNA sequences were analyzed using bioinformatics programs available online. Translation was performed using ExPASy Translation Tool 6.0 (<underline><ext-link xlink:href="http://web.expasy.org/translate/" ext-link-type="uri">http://web.expasy.org/translate/</ext-link></underline>), amino acid alignment was performed using BioEdit 7.1.5.0, and the peptides were aligned with <italic toggle="yes">C. trachomatis</italic> proteins (taxid 813) deposited in the NCBI BLAST database. The search for <italic toggle="yes">C. trachomatis</italic> proteins for linear alignment was performed using the protein blast platform through UniProtKB/Swiss-Pro. The Universal Protein Resource (UniProt) database and the Protein Data Bank were used to obtain information on the localization, function and three-dimensional structure of the aligned peptides using the Pepitope Server (<underline><ext-link xlink:href="http://pepitope.tau.ac.il/index.html" ext-link-type="uri">http://pepitope.tau.ac.il/index.html</ext-link></underline>).</p></sec></sec><sec id="s0002-s2003"><title>Phage ELISA</title><p>Standardization tests were performed to determine the phage concentration containing the selected peptides and the most appropriate antibody dilution to be used. A microtiter plate (Nunc-Immune&#x02122; Plate MaxiSorp&#x02122; Surface) was sensitized with 10 &#x000b5;g/well anti-M13 monoclonal antibody (GE Healthcare) diluted in 50 mM carbonate buffer, pH 9.6 (1:500), and incubated overnight at 4 &#x000b0;C. After washing, the plate was blocked with 300 &#x000b5;L of 1x PBS + Molico powdered milk (5%) for 1 hour at 37 &#x000b0;C. The phage clones were diluted in 1x PBS, added to the plate and incubated for 1 hour at 37 &#x000b0;C. The plate was washed, and pools of CT+ and NC plasma were added. After washing, peroxidase-conjugated anti-human IgG (Sigma/Aldrich) diluted in 1x PBS + 0.1% Tween (1:5000) was added, and the plate was incubated for 1 hour at 37 &#x000b0;C. Finally, TMB was added, and the reaction was stopped by the addition of H<sub>2</sub>SO<sub>4</sub> (2 M). The absorbance values were measured using a reading filter at a wavelength of 450 nm. The cutoff value was &#x02265;0.364, with a standard deviation &#x02265;2.</p><p>After standardization of the ideal conditions using a plasma pool, another ELISA was performed with individual patient and control samples to verify the reactivity with each selected phage. The method used was the same as that used in the phage ELISA (11 additional different CT+ and NC+ samples).</p></sec><sec id="s0002-s2004"><title>Statistical Analysis</title><p>GraphPad Prism version 6.0 (GraphPad Prism Software Inc., USA) was used to calculate the area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, specificity and positive likelihood ratio (LR+).</p></sec></sec><sec id="s0003"><title>Results</title><sec id="s0003-s2001"><title>Prevalidation with Phage ELISA, Optimization and Reactivity with Individual Samples</title><p>Biopanning and sequencing allowed the selection and identification of 25 clones, which were evaluated in a prevalidation using an immunoenzymatic ELISA. The probable mimetics of <italic toggle="yes">C. trachomatis</italic> were selected from clones that showed the highest ratio between the optical density (OD) for the CT+ and CP+ pools and the highest ratio between the OD for the CT+ and NC pools. Clones G1, A5, G5, H5, C6 and H7 were selected for the optimization phase of the test (<xref rid="f0001" ref-type="fig">Figure 1A</xref>). Among these clones, those with a CT+/CP+ OD less than 0.364 or CT+/NC OD less than 2 were excluded from the reactivity test with individual samples.<fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p>Comparison of the reactivity of clones identified by phage display between the sera of patients who were positive and negative for <italic toggle="yes">C. trachomatis</italic>. (<bold>A</bold>) Phage ELISA with the clones selected by biopanning and sequenced. The clones marked with &#x0201c;*&#x0201d; were selected for use in the ELISA optimization test. Evaluation of reactivity by phage ELISA of individual samples with clones G1 (<bold>B</bold>), H5 (<bold>C</bold>), H7 (<bold>D</bold>) and C6 (<bold>E</bold>).</p></caption><graphic xlink:href="IDR-15-4935-g0001" content-type="print-only" position="float"/></fig></p><p>Clones G1, H5, H7 and C6 were selected for the final phage ELISA test, which evaluated the reactivity with individual samples. The reactivity of the samples indicated the same pattern among the different clones evaluated (<xref rid="f0001" ref-type="fig">Figure 1</xref>B-<xref rid="f0001" ref-type="fig">E</xref>).</p></sec><sec id="s0003-s2002"><title>Sequencing and Bioinformatics Analysis</title><p>The four clones that showed the best performance in the ELISAs were selected for bioinformatics analysis. All of them presented primers and terminators, and the 21 nucleotides corresponded to seven amino acids. After linear alignment of the amino acid sequences of peptides G1, H5, H7 and C6 aligned with amino acid sequences of different <italic toggle="yes">C. trachomatis</italic> proteins (<xref rid="t0001" ref-type="table">Table 1</xref>).<table-wrap position="float" id="t0001"><label>Table 1</label><caption><p>Amino Acid Sequences of the Clones That Showed the Best Performance in the Phage ELISA Tests</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Clone</th><th rowspan="1" colspan="1">Peptide</th><th rowspan="1" colspan="1">Alignment</th><th rowspan="1" colspan="1">Query cover</th><th rowspan="1" colspan="1">%Id</th><th rowspan="1" colspan="1">Putative target</th><th rowspan="1" colspan="1">GenBank</th></tr></thead><tbody><tr><td rowspan="3" colspan="1">G1</td><td rowspan="3" colspan="1">AC<bold>MKVSPDS</bold>CGGGS</td><td rowspan="1" colspan="1">SPDSCGGGS</td><td rowspan="3" colspan="1">74%</td><td rowspan="3" colspan="1">77.7%</td><td rowspan="3" colspan="1">Cell wall-associated hydrolase domain-containing protein</td><td rowspan="3" colspan="1">CRH69585.1</td></tr><tr><td rowspan="1" colspan="1">SPDS G GS</td></tr><tr><td rowspan="1" colspan="1">SPDS-GSGS</td></tr><tr><td rowspan="3" colspan="1">H5</td><td rowspan="3" colspan="1">AC<bold>NHARTLT</bold>CGGGS</td><td rowspan="1" colspan="1">HART&#x02013;LTC</td><td rowspan="3" colspan="1">71%</td><td rowspan="3" colspan="1">66.6%</td><td rowspan="3" colspan="1">Glycerol-3-phosphate acyltransferase PlsX</td><td rowspan="3" colspan="1">CRH67789.1</td></tr><tr><td rowspan="1" colspan="1">HART L C</td></tr><tr><td rowspan="1" colspan="1">HARTQPLVC</td></tr><tr><td rowspan="3" colspan="1">C6</td><td rowspan="3" colspan="1">AC<bold>YHHDSRG</bold>CGGGS</td><td rowspan="1" colspan="1">YHHD-SRGC</td><td rowspan="3" colspan="1">57%</td><td rowspan="3" colspan="1">77.7%</td><td rowspan="3" colspan="1">Transposase and inactivated derivatives</td><td rowspan="3" colspan="1">CPR81983.1</td></tr><tr><td rowspan="1" colspan="1">YHHD SR C</td></tr><tr><td rowspan="1" colspan="1">YHHDPSRSC</td></tr><tr><td rowspan="3" colspan="1">H7</td><td rowspan="3" colspan="1">AC<bold>ALPSDRT</bold>CGGGS</td><td rowspan="1" colspan="1">LPSDR</td><td rowspan="3" colspan="1">64%</td><td rowspan="3" colspan="1">100%</td><td rowspan="3" colspan="1">GTP-binding protein</td><td rowspan="3" colspan="1">CRH84351.1</td></tr><tr><td rowspan="1" colspan="1">LPSDR</td></tr><tr><td rowspan="1" colspan="1">LPSDR</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><bold>Abbreviation</bold>: Id, identification.</p></fn></table-wrap-foot></table-wrap>
</p><p>The amino acid sequences were aligned with the proteins deposited in GenBank (NCBI BLAST database) to compare the homology between the sequences obtained and the <italic toggle="yes">C. trachomatis</italic> proteins. The peptides of the evaluated clones were analyzed with regard to the conformational structure of the identified <italic toggle="yes">C. trachomatis</italic> proteins. All the peptides of the clones had sequences that were exposed to several investigated proteins, and the best fit alignment of the four clones was observed on the surface of the protein known as chlamydial protease/proteasome-like activity factor (CPAF; Protein Data Bank accession number: 3DOR; <xref rid="f0002" ref-type="fig">Figure 2</xref>).<fig position="float" id="f0002" fig-type="figure"><label>Figure 2</label><caption><p>Conformational alignment of peptides from clones G1, H5, C6 and H7 in CPAF of <italic toggle="yes">C. trachomatis</italic>.</p></caption><graphic xlink:href="IDR-15-4935-g0002" content-type="print-only" position="float"/></fig></p></sec><sec id="s0003-s2003"><title>Area Under the Curve, Sensitivity, Specificity and LRs</title><p>Phage ELISA indicated that the four clones presented equal sensitivity and specificity values, a statistically significant <italic toggle="yes">p</italic> value (<italic toggle="yes">p &#x0003c;</italic> 0.05) and high LR+ values (<xref rid="f0003" ref-type="fig">Figure 3</xref>). The sensitivity and specificity values for each clone were plotted on an ROC curve, showing AUCs with satisfactory and equivalent values (<xref rid="f0003" ref-type="fig">Figure 3</xref>).<fig position="float" id="f0003" fig-type="figure"><label>Figure 3</label><caption><p>Statistical parameters of the mimetic peptides. Sensitivity, specificity, likelihood ratio (LR) and area under the curve (AUC) and ROC curve.</p></caption><graphic xlink:href="IDR-15-4935-g0003" content-type="print-only" position="float"/></fig></p></sec></sec><sec id="s0004"><title>Discussion</title><p>Despite the absence of sensitive and specific assays for the serological diagnosis of <italic toggle="yes">C. trachomatis</italic>, the present study is unprecedented because no record of the selection of mimetic peptides for the bacterium is available from commercial peptide libraries using phage display technology.</p><p>The amino acid sequences of clones G1, H5, C6 and H7 were aligned with <italic toggle="yes">C. trachomatis</italic> proteins; however, they were not related to MOMPs, proteins usually present as antigens in immunoenzymatic assays for the detection of antibodies. From the UniProt database, the proteins to which the clones aligned were shown to be located in the transmembrane region of the bacterium.</p><p>The peptide from clone G1 (ACMKVSPDSCGGGS) showed similarity with a protein containing a hydrolase domain associated with the cell wall. Hydrolases are ubiquitous enzymes that act on cell division, cell wall rearrangement, bacterial growth and cell lysis. The activity of hydrolases associated with the cell wall may have secondary effects on several physiological functions, such as bacterial adhesion, biofilm formation, protein secretion, conjugation, virulence and immune responses.<xref rid="cit0027" ref-type="bibr">27</xref>,<xref rid="cit0028" ref-type="bibr">28</xref>,<xref rid="cit0041" ref-type="bibr">41</xref>,<xref rid="cit0042" ref-type="bibr">42</xref></p><p>The peptide from clone H5 (ACNHARTLTCGGGS) aligned with the protein glycerol-3-phosphate acyltransferase, which acts in the biosynthetic pathway for the formation of phosphatidic acid in the biosynthesis of bacterial membrane phospholipids, whose main function is maintaining plasma membrane structure.<xref rid="cit0043" ref-type="bibr">43</xref>,<xref rid="cit0044" ref-type="bibr">44</xref> Other proteins have been observed in metabolic model studies, providing details about the metabolic adaptations of <italic toggle="yes">C. trachomatis</italic> during infection, which helps in understanding important details of the biology of <italic toggle="yes">Chlamydia</italic> infection.<xref rid="cit0045" ref-type="bibr">45</xref></p><p>The peptide from clone C6 (ACYHHDSRGCGGGS) aligned with transposase enzymes and inactivated derivatives. Transposases recognize the start and end points of a transposon, catalyzing the transposition to another gene region. These transposition elements and the associated transposase genes are the most abundant and ubiquitous in nature and are essential for adaptation and biological diversity.<xref rid="cit0046" ref-type="bibr">46</xref> Through mutagenesis studies, sets of genes essential for <italic toggle="yes">C. trachomatis</italic> may be able to be identified to gain a better understanding of the biology of bacterial infection, leading to the discovery of new drug or vaccine targets.<xref rid="cit0047" ref-type="bibr">47</xref></p><p>Clone H7 (ACALPSDRTCGGGS) aligned with a GTP-binding protein. GTP is related to the modulation of host signaling pathways and may play an important role in the pathogenesis of <italic toggle="yes">Chlamydia</italic>, comparable to the activities of MOMP.<xref rid="cit0048" ref-type="bibr">48</xref> This mimetic peptide can be used in assays to describe new signaling pathways of components involved in the pathogenesis of <italic toggle="yes">Chlamydia</italic> infection.</p><p>The three-dimensional alignment of the clones with different proteins of <italic toggle="yes">C. trachomatis</italic> revealed CPAF as the best match.<xref rid="cit0049" ref-type="bibr">49</xref>,<xref rid="cit0050" ref-type="bibr">50</xref> This decision was reached considering that the structure of CPAF accommodated all four clones in contrast to the other proteins for which maximum matches ranged from 1 to 3. The pathogenic mechanism of infection and the diseases associated with <italic toggle="yes">Chlamydia</italic> infection result from the onset of an inflammatory process, which is not well understood, and to survive in the host, <italic toggle="yes">Chlamydia</italic> must evade the host&#x02019;s immune response. CPAF has different and important functions in the evasion of the immune response by mechanisms that may include cleaving or degrading host proteins and acting as a &#x0201c;strong virulence factor&#x0201d; during infection.<xref rid="cit0050" ref-type="bibr">50&#x02013;54</xref> The absence of CPAF is crucial in the multiplication of <italic toggle="yes">Chlamydia</italic> and implies the absence of the formation of infectious elementary bodies.<xref rid="cit0053" ref-type="bibr">53</xref> Importantly, CPAF is highly conserved in <italic toggle="yes">Chlamydia</italic> species, both regarding its structural composition and its functionality, eg, when examining a similar protease activation mechanism in different <italic toggle="yes">Chlamydia</italic> species.<xref rid="cit0055" ref-type="bibr">55</xref></p><p>The peptides of clones G1, H5, C6 and H7 aligned with sequences located on the surface of CPAF; thus, the clones showed a promising immunogenic role that should be investigated, either individually or on a multiplex basis. The selection of these clones seems to suggest that MOMPs are not the only important proteins for the diagnosis of <italic toggle="yes">C. trachomatis</italic> infection. As a novel suggestion, for the first time, proteins involved in the metabolic processes of the bacterium also have diagnostic potential and should be investigated. The targeting of large quantities of antibodies to CPAF, especially the epitopes defined by clones G1, H5, C6 and H7 can detect the presence of active infections and possibly the persistence of the bacterium considering the functions associated with CPAF identified to date.</p><p>However, the reactivity of the mimetic peptides obtained with serum samples positive for <italic toggle="yes">C. trachomatis</italic> IgG revealed that the four clones showed high sensitivity (90.91%) and low specificity (54.55%). The immunoenzymatic assay resulted in LR values for the clones indicative of a twofold greater likelihood of detecting a positive result among infected compared to noninfected samples. In addition, the clones showed AUC values above 0.8, indicating the high discriminative power of the test between the disease and health states. From a clinical perspective, a screening test that can be used as a point-of-care test is crucial to initiate immediate treatment for <italic toggle="yes">C. trachomatis</italic> infections.</p><p>Other examples have been described for viral infectious agents (low antigenic complexity), such as hepatitis E virus,<xref rid="cit0056" ref-type="bibr">56</xref> bacterial infectious agents, such as <italic toggle="yes">M. tuberculosis</italic>,<xref rid="cit0057" ref-type="bibr">57</xref> and those with greater antigenic complexity, such as <italic toggle="yes">Strongyloides</italic>.<xref rid="cit0058" ref-type="bibr">58</xref> The change in focus in the selection of traditional antigens indicates good results for the synthesis and selection of mimetic peptides, whose results reach values better than the typical methods using structural and functional/metabolic proteins, such as those in the present study.</p><p>The phage display method was used to evaluate <italic toggle="yes">C. trachomatis</italic> infection using single-chain variable fragment (scFv) antibodies presented by phages to analyze the complexity of the surface molecules of the elementary body of <italic toggle="yes">Chlamydia</italic>; this approach allowed the detection and identification of a variety of elementary body-associated antigens and host cell antigens.<xref rid="cit0059" ref-type="bibr">59</xref> Thus, the technique was demonstrated to be important for evaluating infection using different approaches because it allowed the description of relevant peptides, such as those described in the present study, that can be explored in future assays not only for laboratory diagnosis but also for understanding the pathogenesis and treatment of diseases. The selection of clones indicated peptides different from those that are usually selected as antigens in assays for the detection of antibodies against <italic toggle="yes">C. trachomatis</italic>. Notably, the selection of antigens for diagnostic use is more difficult in regard to the antigenic complexity of bacteria. The opportunity to select the four peptides is novel in that they relate to a protein of the metabolic pathway of <italic toggle="yes">C. trachomatis</italic> that differs from what has been used to date. In contrast, due to the innovation involved, data with which to compare the results obtained are lacking; thus, the peptides can be inferred to have sufficient relevance for future evaluation for the purpose of diagnostic screening for <italic toggle="yes">C. trachomatis</italic> infection. The approach used to select different epitopes in different proteins of the infectious agent has also been successfully attempted using other selection methods for HTLV as a novel opportunity for diagnosis.<xref rid="cit0060" ref-type="bibr">60</xref></p><p>In the present study, the phage display method showed the importance of using CPAF for diagnosis, but this protein has already been used in a murine model as a sufficient immunizer against <italic toggle="yes">C. muridarum</italic>, inducing protective CD4<sup>+</sup> T lymphocyte-dependent immunity and IFN-&#x003b3; production.<xref rid="cit0061" ref-type="bibr">61</xref> The description of clones G1, H5, C6 and H7 and the conserved structure of CPAF indicate the presence of four epitopes that are also conserved, a finding that can be tested for the production of future vaccines with universal use for human primates and other animals infected by <italic toggle="yes">Chlamydia</italic> species.</p><p>In conclusion, the use of the phage display methodology allowed bioprospection of mimetic peptides of <italic toggle="yes">C. trachomatis</italic>. Four phage clones were associated with the metabolism of the bacterium, which are promising peptides to be used in diagnostic platforms using immunochromatography or biosensors for an efficient, rapid, easy-to-perform and low-cost test.</p></sec></body><back><sec id="s0005"><title>Ethics Approval and Informed Consent</title><p>The present study was approved by the Ethics Committee for Research with Human Beings of Funda&#x000e7;&#x000e3;o Hemopa (opinion 0011.0324.000-1) in accordance with the Declaration of Helsinki. The participants were informed about the objectives of the study, and those who agreed to participate signed an informed consent form.</p></sec><sec id="s0006"><title>Author Contributions</title><p>All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.</p></sec><sec sec-type="COI-statement" id="s0007"><title>Disclosure</title><p>The authors declare that they have no competing interests.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Schachter</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Caldwell</surname>
<given-names>HD</given-names></string-name>. <article-title>Chlamydiae</article-title>. <source><italic toggle="yes">Annu Rev Microbiol</italic></source>. <year>1980</year>;<volume>34</volume>:<fpage>285</fpage>&#x02013;<lpage>309</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.mi.34.100180.001441</pub-id><pub-id pub-id-type="pmid">7002026</pub-id></mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Weinstock</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Dean</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bolan</surname>
<given-names>G</given-names></string-name>. <article-title>Chlamydia trachomatis infection</article-title>. <source><italic toggle="yes">Infect Dis Clin North Am</italic></source>. <year>1994</year>;<volume>8</volume>:<fpage>797</fpage>&#x02013;<lpage>819</lpage>.<pub-id pub-id-type="pmid">7890933</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Inman</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Whittum-Hudson</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Schumacher</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Hudson</surname>
<given-names>AP</given-names></string-name>. <article-title>Chlamydia and associated arthritis</article-title>. <source><italic toggle="yes">Curr Opin Rheumatol</italic></source>. <year>2000</year>;<volume>12</volume>:<fpage>254</fpage>&#x02013;<lpage>262</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00002281-200007000-00004</pub-id><pub-id pub-id-type="pmid">10910176</pub-id></mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Witkin</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Minis</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Athanasiou</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Leizer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Linhares</surname>
<given-names>IM</given-names></string-name>. <article-title>Chlamydia trachomatis: the Persistent Pathogen</article-title>. <source><italic toggle="yes">Clin Vaccine Immunol</italic></source>. <year>2017</year>;<volume>24</volume>(<issue>10</issue>):<fpage>e00203</fpage>&#x02013;<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1128/CVI.00203-17</pub-id><pub-id pub-id-type="pmid">28835360</pub-id></mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>den Heijer</surname>
<given-names>CDJ</given-names></string-name>, <string-name><surname>Hoebe</surname>
<given-names>CJPA</given-names></string-name>, <string-name><surname>Driessen</surname>
<given-names>JHM</given-names></string-name>, et al. <article-title>Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: a Retrospective Cohort Study Among Primary Care Patients</article-title>. <source><italic toggle="yes">Clin Infect Dis</italic></source>. <year>2019</year>;<volume>69</volume>(<issue>9</issue>):<fpage>1517</fpage>&#x02013;<lpage>1525</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/ciz429</pub-id><pub-id pub-id-type="pmid">31504315</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="webpage"><collab>World Health Organization</collab>. <article-title>Sexually transmitted infections</article-title>; <year>2019</year>. <comment>Available from</comment>: <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis</ext-link>). <date-in-citation>Accessed <month>December</month>
<day>12</day>, 2021</date-in-citation>.</mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Matsumoto</surname>
<given-names>A</given-names></string-name>. <article-title>Electron microscopic observations of surface projections on Chlamydia psittaci reticulate bodies</article-title>. <source><italic toggle="yes">J Bacteriol</italic></source>. <year>1982</year>;<volume>150</volume>(<issue>1</issue>):<fpage>358</fpage>&#x02013;<lpage>364</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.150.1.358-364.1982</pub-id><pub-id pub-id-type="pmid">7061397</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Abdelrahman</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Belland</surname>
<given-names>RJ</given-names></string-name>. <article-title>The chlamydial developmental cycle</article-title>. <source><italic toggle="yes">FEMS Microbiol Rev</italic></source>. <year>2005</year>;<volume>29</volume>:<fpage>949</fpage>&#x02013;<lpage>959</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.femsre.2005.03.002</pub-id><pub-id pub-id-type="pmid">16043254</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Moulder</surname>
<given-names>JW</given-names></string-name>. <article-title>The relation of the psittacosis group (Chlamydiae) to bacteria and viruses</article-title>. <source><italic toggle="yes">Annu Rev Microbiol</italic></source>. <year>1966</year>;<volume>20</volume>:<fpage>107</fpage>&#x02013;<lpage>130</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.mi.20.100166.000543</pub-id><pub-id pub-id-type="pmid">5330228</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Elwell</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mirrashidi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Engel</surname>
<given-names>J</given-names></string-name>. <article-title>Chlamydia cell biology and pathogenesis</article-title>. <source><italic toggle="yes">Nat Rev Microbiol</italic></source>. <year>2016</year>;<volume>14</volume>(<issue>6</issue>):<fpage>385</fpage>&#x02013;<lpage>400</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro.2016.30</pub-id><pub-id pub-id-type="pmid">27108705</pub-id></mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Solomon</surname>
<given-names>AW</given-names></string-name>, <string-name><surname>Peeling</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>Foster</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mabey</surname>
<given-names>DCW</given-names></string-name>. <article-title>Diagnosis and Assessment of Trachoma</article-title>. <source><italic toggle="yes">Clin Microbiol Rev</italic></source>. <year>2004</year>;<volume>17</volume>(<issue>4</issue>):<fpage>982</fpage>&#x02013;<lpage>1011</lpage>. doi:<pub-id pub-id-type="doi">10.1128/CMR.17.4.982-1011.2004</pub-id><pub-id pub-id-type="pmid">15489358</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Caldwell</surname>
<given-names>HD</given-names></string-name>, <string-name><surname>Kromhout</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Schachter</surname>
<given-names>J</given-names></string-name>. <article-title>Purification and partial characterization of the major outer membrane protein of <italic toggle="yes">Chlamydia trachomatis</italic></article-title>. <source><italic toggle="yes">Infect Immun</italic></source>. <year>1981</year>;<volume>31</volume>(<issue>3</issue>):<fpage>1161</fpage>&#x02013;<lpage>1176</lpage>. doi:<pub-id pub-id-type="doi">10.1128/iai.31.3.1161-1176.1981</pub-id><pub-id pub-id-type="pmid">7228399</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Hatch</surname>
<given-names>TP</given-names></string-name>, <string-name><surname>Miceli</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sublett</surname>
<given-names>JE</given-names></string-name>. <article-title>Synthesis of disulfide-bonded outer membrane proteins during the developmental cycle of Chlamydia psittaci and Chlamydia trachomatis</article-title>. <source><italic toggle="yes">J Bacteriol</italic></source>. <year>1986</year>;<volume>165</volume>(<issue>2</issue>):<fpage>379</fpage>&#x02013;<lpage>385</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.165.2.379-385.1986</pub-id><pub-id pub-id-type="pmid">3944054</pub-id></mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Stephens</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Sanchez-Pescador</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wagar</surname>
<given-names>EA</given-names></string-name>. <article-title>Diversity of <italic toggle="yes">Chlamydia trachomatis</italic> major outer membrane protein genes</article-title>. <source><italic toggle="yes">J Bacteriol</italic></source>. <year>1987</year>;<volume>169</volume>(<issue>9</issue>):<fpage>3879</fpage>&#x02013;<lpage>3885</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.169.9.3879-3885.1987</pub-id><pub-id pub-id-type="pmid">3040664</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Morr&#x000e9;</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Ossewaarde</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Lan</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Serotyping and Genotyping of Genital Chlamydia trachomatis Isolates Reveal Variants of Serovars Ba, G, and J as Confirmed by omp1 Nucleotide Sequence Analysis</article-title>. <source><italic toggle="yes">J Clin Microbiol</italic></source>. <year>1998</year>;<volume>36</volume>(<issue>2</issue>):<fpage>345</fpage>&#x02013;<lpage>351</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.36.2.345-351</pub-id><pub-id pub-id-type="pmid">9466739</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Kari</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Whitmire</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Crane</surname>
<given-names>DD</given-names></string-name>, et al. <article-title>Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine</article-title>. <source><italic toggle="yes">J Immunol</italic></source>. <year>2009</year>;<volume>182</volume>(<issue>12</issue>):<fpage>8063</fpage>&#x02013;<lpage>8070</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.0804375</pub-id><pub-id pub-id-type="pmid">19494332</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Kariagina</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Alekseevski&#x0012d;</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Spirin</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Zigangirova</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Gintsburg</surname>
<given-names>AL</given-names></string-name>. <article-title>Effector proteins of Chlamydia</article-title>. <source><italic toggle="yes">Mol Biol (Mosk)</italic></source>. <year>2009</year>;<volume>43</volume>(<issue>6</issue>):<fpage>963</fpage>&#x02013;<lpage>983</lpage>.<pub-id pub-id-type="pmid">20088373</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Treharne</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Forsey</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>BJ</given-names></string-name>. <article-title>Chlamydial serology</article-title>. <source><italic toggle="yes">Br Med Bull</italic></source>. <year>1983</year>;<volume>39</volume>(<issue>2</issue>):<fpage>194</fpage>&#x02013;<lpage>200</lpage>. doi:<pub-id pub-id-type="doi">10.1093/oxfordjournals.bmb.a071815</pub-id><pub-id pub-id-type="pmid">6347331</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Ozanne</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lefebvre</surname>
<given-names>J</given-names></string-name>. <article-title>Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections</article-title>. <source><italic toggle="yes">Can J Microbiol</italic></source>. <year>1992</year>;<volume>38</volume>(<issue>11</issue>):<fpage>1185</fpage>&#x02013;<lpage>1189</lpage>. doi:<pub-id pub-id-type="doi">10.1139/m92-194</pub-id><pub-id pub-id-type="pmid">1477792</pub-id></mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Herkenhoff</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Gaulke</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Vieira</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Ferreira</surname>
<given-names>OS</given-names></string-name>, <string-name><surname>Pitlovanciv</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Remualdo</surname>
<given-names>VR</given-names></string-name>. <article-title>Preval&#x000ea;ncia de Chlamydia trachomathis em amostras endocervicais de mulheres em S&#x000e3;o Paulo e Santa Catarina pela PCR</article-title>. <source><italic toggle="yes">J Bras Patol Med Lab</italic></source>. <year>2012</year>;<volume>48</volume>(<issue>5</issue>):<fpage>323</fpage>&#x02013;<lpage>327</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S1676-24442012000500004</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="webpage"><collab>Brasil. Minist&#x000e9;rio da Sa&#x000fa;de</collab>. <article-title>Diagn&#x000f3;stico Laboratorial da Clam&#x000ed;dia</article-title>; <year>1997</year>. <comment>Available from</comment>: <ext-link xlink:href="https://bvsms.saude.gov.br/bvs/publicacoes/cd05_09.pdf" ext-link-type="uri">https://bvsms.saude.gov.br/bvs/publicacoes/cd05_09.pdf</ext-link>. <date-in-citation>Accessed <month>May</month>
<day>17</day>, 2022</date-in-citation>.</mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Black</surname>
<given-names>CM</given-names></string-name>. <article-title>Current methods of laboratory diagnosis of Chlamydia trachomatis infections</article-title>. <source><italic toggle="yes">Clin Microbiol Rev</italic></source>. <year>1997</year>;<volume>10</volume>(<issue>1</issue>):<fpage>160</fpage>&#x02013;<lpage>184</lpage>. doi:<pub-id pub-id-type="doi">10.1128/CMR.10.1.160</pub-id><pub-id pub-id-type="pmid">8993862</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Hamdad</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Orfila</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Boulanger</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Eb</surname>
<given-names>F</given-names></string-name>. <article-title>Chlamydia trachomatis urogenital infections in women. Best diagnostic approaches</article-title>. <source><italic toggle="yes">Gynecol Obstet Fertil</italic></source>. <year>2004</year>;<volume>32</volume>(<issue>12</issue>):<fpage>1064</fpage>&#x02013;<lpage>1074</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.gyobfe.2004.10.017</pub-id><pub-id pub-id-type="pmid">15589784</pub-id></mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Jackson</surname>
<given-names>B</given-names></string-name>. <article-title>Relative cost-effectiveness of different tests for Chlamydia trachomatis</article-title>. <source><italic toggle="yes">Ann Intern Med</italic></source>. <year>2005</year>;<volume>142</volume>(<issue>4</issue>):<fpage>308</fpage>. doi:<pub-id pub-id-type="doi">10.7326/0003-4819-142-4-200502150-00019</pub-id><pub-id pub-id-type="pmid">15710968</pub-id></mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Persson</surname>
<given-names>K</given-names></string-name>. <article-title>The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections</article-title>. <source><italic toggle="yes">Best Pract Res Clin Obstet Gynaecol</italic></source>. <year>2002</year>;<volume>16</volume>(<issue>6</issue>):<fpage>801</fpage>&#x02013;<lpage>814</lpage>. doi:<pub-id pub-id-type="doi">10.1053/beog.2002.0321</pub-id><pub-id pub-id-type="pmid">12473283</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Johnson</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Horner</surname>
<given-names>P</given-names></string-name>. <article-title>A new role for Chlamydia trachomatis serology?</article-title>
<source><italic toggle="yes">Sex Transm Infect</italic></source>. <year>2008</year>;<volume>84</volume>(<issue>2</issue>):<fpage>79</fpage>&#x02013;<lpage>80</lpage>. doi:<pub-id pub-id-type="doi">10.1136/sti.2007.028472</pub-id><pub-id pub-id-type="pmid">18256104</pub-id></mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Ishak</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Costa</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Almeida</surname>
<given-names>NC</given-names></string-name>, et al. <article-title>Chlamydia trachomatis serotype A infections in the Amazon region of Brazil: prevalence, entry and dissemination</article-title>. <source><italic toggle="yes">Rev Soc Bras Med Trop</italic></source>. <year>2015</year>;<volume>48</volume>(<issue>2</issue>):<fpage>170</fpage>&#x02013;<lpage>174</lpage>. doi:<pub-id pub-id-type="doi">10.1590/0037-8682-0038-2015</pub-id><pub-id pub-id-type="pmid">25992931</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Ferreira</surname>
<given-names>GRON</given-names></string-name>, <string-name><surname>Freitas</surname>
<given-names>FB</given-names></string-name>, <string-name><surname>Queiroz</surname>
<given-names>MAF</given-names></string-name>, et al. <article-title>Epidemiology and risk factors for Chlamydia trachomatis, Treponema pallidum, Hepatitis B Virus and Hepatitis C Virus in the Maraj&#x000f3; Archipelago, Brazilian Amazon</article-title>. <source><italic toggle="yes">J Community Med Health Educ</italic></source>. <year>2019</year>;<volume>9</volume>:<fpage>643</fpage>. doi:<pub-id pub-id-type="doi">10.4172/2161-0711.1000643</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Rahman</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Kaltenboeck</surname>
<given-names>B</given-names></string-name>. <article-title>Multipeptide assays for sensitive and differential detection of anti-chlamydia trachomatis antibodies</article-title>. <source><italic toggle="yes">J Infect Dis</italic></source>. <year>2021</year>;<volume>224</volume>(<issue>12 Suppl 2</issue>):<fpage>S86</fpage>&#x02013;<lpage>S95</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jiab016</pub-id><pub-id pub-id-type="pmid">34396415</pub-id></mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Rahman</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Darville</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Russell</surname>
<given-names>AN</given-names></string-name>, et al. <article-title>Discovery of Human-Specific Immunodominant Chlamydia trachomatis B Cell Epitopes</article-title>. <source><italic toggle="yes">mSphere</italic></source>. <year>2018</year>;<volume>3</volume>(<issue>4</issue>):<fpage>e00246</fpage>&#x02013;<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1128/mSphere.00246-18</pub-id><pub-id pub-id-type="pmid">30068558</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Smith</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Petrenko</surname>
<given-names>VA</given-names></string-name>. <article-title>Phage Display</article-title>. <source><italic toggle="yes">Chem Rev</italic></source>. <year>1997</year>;<volume>97</volume>(<issue>2</issue>):<fpage>391</fpage>&#x02013;<lpage>410</lpage>. doi:<pub-id pub-id-type="doi">10.1021/cr960065d</pub-id><pub-id pub-id-type="pmid">11848876</pub-id></mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Arap</surname>
<given-names>MA</given-names></string-name>. <article-title>Phage display technology &#x02013; applications and innovations</article-title>. <source><italic toggle="yes">Genet Mol Biol</italic></source>. <year>2005</year>;<volume>28</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S1415-47572005000100001</pub-id></mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Silva</surname>
<given-names>JRA</given-names></string-name>, <string-name><surname>Kawazoe</surname>
<given-names>U</given-names></string-name>. <article-title>Avian anticoccidial activity of a novel membrane interactive peptide selected from phage display libraries</article-title>. <source><italic toggle="yes">Mol Biochem Parasitol</italic></source>. <year>2002</year>;<volume>120</volume>(<issue>1</issue>):<fpage>53</fpage>&#x02013;<lpage>60</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0166-6851(01</pub-id><pub-id pub-id-type="pmid">11849705</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Pande</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Szewczyk</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Grover</surname>
<given-names>AK</given-names></string-name>. <article-title>Phage display: concept, innovations, applications and future</article-title>. <source><italic toggle="yes">Biotechnol Adv</italic></source>. <year>2010</year>;<volume>28</volume>(<issue>6</issue>):<fpage>849</fpage>&#x02013;<lpage>858</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biotechadv.2010.07.004</pub-id><pub-id pub-id-type="pmid">20659548</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Lopes</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Queiroz</surname>
<given-names>MAF</given-names></string-name>, <string-name><surname>Gomes</surname>
<given-names>STM</given-names></string-name>, <string-name><surname>Vallinoto</surname>
<given-names>ACR</given-names></string-name>, <string-name><surname>Goulart</surname>
<given-names>LR</given-names></string-name>, <string-name><surname>Ishak</surname>
<given-names>R</given-names></string-name>. <article-title>Phage display: an important tool in the discovery of peptides with anti-HIV activity</article-title>. <source><italic toggle="yes">Biotechnol Adv</italic></source>. <year>2018</year>;<volume>36</volume>(<issue>7</issue>):<fpage>1847</fpage>&#x02013;<lpage>1854</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.07.003</pub-id><pub-id pub-id-type="pmid">30012540</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Martins</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Reis</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Azevedo</surname>
<given-names>HS</given-names></string-name>. <article-title>Phage Display Technology in Biomaterials Engineering: progress and Opportunities for Applications in Regenerative Medicine</article-title>. <source><italic toggle="yes">ACS Chem Biol</italic></source>. <year>2016</year>;<volume>11</volume>:<fpage>2962</fpage>&#x02013;<lpage>2980</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acschembio.5b00717</pub-id><pub-id pub-id-type="pmid">27661443</pub-id></mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Saw</surname>
<given-names>PE</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>EW</given-names></string-name>. <article-title>Phage display screening of therapeutic peptide for cancer targeting and therapy</article-title>. <source><italic toggle="yes">Protein Cell</italic></source>. <year>2019</year>;<volume>10</volume>(<issue>11</issue>):<fpage>787</fpage>&#x02013;<lpage>807</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13238-019-0639-7</pub-id><pub-id pub-id-type="pmid">31140150</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Portes</surname>
<given-names>LDS</given-names></string-name>, <string-name><surname>Kioshima</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>de Camargo</surname>
<given-names>ZP</given-names></string-name>, <string-name><surname>Batista</surname>
<given-names>WL</given-names></string-name>, <string-name><surname>Xander</surname>
<given-names>P</given-names></string-name>. <article-title>Subtractive phage display selection for screening and identification of peptide sequences with potential use in serodiagnosis of paracoccidioidomycosis caused by Paracoccidioides brasiliensis</article-title>. <source><italic toggle="yes">Lett Appl Microbiol</italic></source>. <year>2017</year>;<volume>65</volume>(<issue>5</issue>):<fpage>346</fpage>&#x02013;<lpage>353</lpage>. doi:<pub-id pub-id-type="doi">10.1111/lam.12788</pub-id><pub-id pub-id-type="pmid">28796894</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Moreira</surname>
<given-names>GMSG</given-names></string-name>, <string-name><surname>K&#x000f6;llner</surname>
<given-names>SMS</given-names></string-name>, <string-name><surname>Helmsing</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Pyruvate dehydrogenase complex-enzyme 2, a new target for Listeria spp. detection identified using combined phage display technologies</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>15267</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-020-72159-4</pub-id><pub-id pub-id-type="pmid">32943681</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="book"><string-name><surname>Barbas</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Burto</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>JK</given-names></string-name>, <string-name><surname>Silverino</surname>
<given-names>GJ</given-names></string-name>. <source><italic toggle="yes">Phage Display: A Laboratory Manual</italic></source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>; <year>2001</year>.</mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Scheurwater</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Reid</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Clarke</surname>
<given-names>AJ</given-names></string-name>. <article-title>Lytic transglycosylases: bacterial space-making autolysins</article-title>. <source><italic toggle="yes">Int J Biochem Cell Biol</italic></source>. <year>2008</year>;<volume>40</volume>(<issue>4</issue>):<fpage>586</fpage>&#x02013;<lpage>591</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biocel.2007.03.018</pub-id><pub-id pub-id-type="pmid">17468031</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Vermassen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Leroy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Talon</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Provot</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Popowska</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Desvaux</surname>
<given-names>M</given-names></string-name>. <article-title>Cell Wall Hydrolases in Bacteria: insight on the Diversity of Cell Wall Amidases, Glycosidases and Peptidases Toward Peptidoglycan</article-title>. <source><italic toggle="yes">Front Microbiol</italic></source>. <year>2019</year>;<volume>10</volume>:<fpage>331</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2019.00331</pub-id><pub-id pub-id-type="pmid">30873139</pub-id></mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Paoletti</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Schujman</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>de Mendoza</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rock</surname>
<given-names>CO</given-names></string-name>. <article-title>Coupling of fatty acid and phospholipid synthesis in Bacillus subtilis</article-title>. <source><italic toggle="yes">J Bacteriol</italic></source>. <year>2007</year>;<volume>189</volume>(<issue>16</issue>):<fpage>5816</fpage>&#x02013;<lpage>5824</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.00602-07</pub-id><pub-id pub-id-type="pmid">17557823</pub-id></mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Lu</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Grimes</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Rock</surname>
<given-names>CO</given-names></string-name>. <article-title>Topology and active site of PlsY: the bacterial acylphosphate: glycerol-3-phosphateacyltransferase</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>. <year>2007</year>;<volume>282</volume>(<issue>15</issue>):<fpage>11339</fpage>&#x02013;<lpage>11346</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M700374200</pub-id><pub-id pub-id-type="pmid">17308305</pub-id></mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rajeeve</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Rudel</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Dandekar</surname>
<given-names>T</given-names></string-name>. <article-title>Comprehensive Flux Modeling of Chlamydia trachomatis Proteome and qRT-PCR Data Indicate Biphasic Metabolic Differences Between Elementary Bodies and Reticulate Bodies During Infection</article-title>. <source><italic toggle="yes">Front Microbiol</italic></source>. <year>2019</year>;<volume>10</volume>:<fpage>2350</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2019.02350</pub-id><pub-id pub-id-type="pmid">31681215</pub-id></mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Fan</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Decker</surname>
<given-names>CM</given-names></string-name>, et al. <article-title>Defensive Function of Transposable Elements in Bacteria</article-title>. <source><italic toggle="yes">ACS Synth Biol</italic></source>. <year>2019</year>;<volume>8</volume>(<issue>9</issue>):<fpage>2141</fpage>&#x02013;<lpage>2151</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acssynbio.9b00218</pub-id><pub-id pub-id-type="pmid">31375026</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>O&#x02019;Neill</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Skilton</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Forster</surname>
<given-names>J</given-names></string-name>, et al. <article-title>An inducible transposon mutagenesis approach for the intracellular human pathogen Chlamydia trachomatis</article-title>. <source><italic toggle="yes">Wellcome Open Res</italic></source>. <year>2021</year>;<volume>6</volume>:<fpage>312</fpage>. doi:<pub-id pub-id-type="doi">10.12688/wellcomeopenres</pub-id><pub-id pub-id-type="pmid">35087955</pub-id></mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Du</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Fuyan Wang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>ZHJ</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>P</given-names></string-name>. <article-title>Localization and Characterization of GTP-Binding Protein CT703 in the Chlamydia trachomatis-Infected Cells</article-title>. <source><italic toggle="yes">Curr Microbiol</italic></source>. <year>2011</year>;<volume>62</volume>(<issue>2</issue>):<fpage>465</fpage>&#x02013;<lpage>471</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00284-010-9730-2</pub-id><pub-id pub-id-type="pmid">20725727</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Structural basis for activation and inhibition of the secreted chlamydia protease CPAF</article-title>. <source><italic toggle="yes">Cell Host Microbe</italic></source>. <year>2008</year>;<volume>4</volume>(<issue>6</issue>):<fpage>529</fpage>&#x02013;<lpage>542</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2008.10.005</pub-id><pub-id pub-id-type="pmid">19064254</pub-id></mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JK</given-names></string-name>, <string-name><surname>S&#x000fc;tterlin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>M</given-names></string-name>. <article-title>CPAF: a Chlamydial protease in search of an authentic substrate</article-title>. <source><italic toggle="yes">PLoS Pathog</italic></source>. <year>2012</year>;<volume>8</volume>(<issue>8</issue>):<fpage>e1002842</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1002842</pub-id><pub-id pub-id-type="pmid">22876181</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Dong</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhong</surname>
<given-names>G</given-names></string-name>. <article-title>Intramolecular dimerization is required for the chlamydia-secreted protease CPAF to degrade host transcriptional factors</article-title>. <source><italic toggle="yes">Infect Immun</italic></source>. <year>2004</year>;<volume>72</volume>(<issue>7</issue>):<fpage>3869</fpage>&#x02013;<lpage>3875</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.72.7.3869-3875.2004</pub-id><pub-id pub-id-type="pmid">15213129</pub-id></mixed-citation></ref><ref id="cit0052"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Paschen</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Christian</surname>
<given-names>JG</given-names></string-name>, <string-name><surname>Vier</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Cytopathicity of Chlamydia is largely reproduced by expression of a single chlamydial protease</article-title>. <source><italic toggle="yes">J Cell Biol</italic></source>. <year>2008</year>;<volume>182</volume>(<issue>1</issue>):<fpage>117</fpage>&#x02013;<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.200804023</pub-id><pub-id pub-id-type="pmid">18625845</pub-id></mixed-citation></ref><ref id="cit0053"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Snavely</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Kokes</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Dunn</surname>
<given-names>JD</given-names></string-name>, et al. <article-title>Reassessing the role of the secreted protease CPAF in Chlamydia trachomatis infection through genetic approaches</article-title>. <source><italic toggle="yes">Pathog Dis</italic></source>. <year>2014</year>;<volume>71</volume>(<issue>3</issue>):<fpage>336</fpage>&#x02013;<lpage>351</lpage>. doi:<pub-id pub-id-type="doi">10.1111/2049-632X.12179</pub-id><pub-id pub-id-type="pmid">24838663</pub-id></mixed-citation></ref><ref id="cit0054"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Patton</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>McCorrister</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Grant</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Chlamydial Protease-Like Activity Factor and Type III Secreted Effectors Cooperate in Inhibition of p65 Nuclear Translocation</article-title>. <source><italic toggle="yes">mBio</italic></source>. <year>2016</year>;<volume>7</volume>(<issue>5</issue>):<fpage>e01427</fpage>&#x02013;<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.1128/mBio.01427-16</pub-id><pub-id pub-id-type="pmid">27677792</pub-id></mixed-citation></ref><ref id="cit0055"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Dong</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Zhong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Arulanandam</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Zhong</surname>
<given-names>G</given-names></string-name>. <article-title>Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species</article-title>. <source><italic toggle="yes">Infect Immun</italic></source>. <year>2005</year>;<volume>73</volume>(<issue>3</issue>):<fpage>1868</fpage>&#x02013;<lpage>1872</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.73.3.1868-1872.2005</pub-id><pub-id pub-id-type="pmid">15731091</pub-id></mixed-citation></ref><ref id="cit0056"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Larralde</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Petrik</surname>
<given-names>J</given-names></string-name>. <article-title>Phage-displayed peptides that mimic epitopes of hepatitis E virus capsid</article-title>. <source><italic toggle="yes">Med Microbiol Immunol</italic></source>. <year>2017</year>;<volume>206</volume>(<issue>4</issue>):<fpage>301</fpage>&#x02013;<lpage>309</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00430-017-0507-0</pub-id><pub-id pub-id-type="pmid">28434129</pub-id></mixed-citation></ref><ref id="cit0057"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>H</given-names></string-name>, et al. <article-title>The mimic epitopes of Mycobacterium tuberculosis screened by phage display peptide library have serodiagnostic potential for tuberculosis</article-title>. <source><italic toggle="yes">Pathog Dis</italic></source>. <year>2016</year>;<volume>74</volume>(<issue>8</issue>):<fpage>ftw091</fpage>. doi:<pub-id pub-id-type="doi">10.1093/femspd/ftw091</pub-id><pub-id pub-id-type="pmid">27609463</pub-id></mixed-citation></ref><ref id="cit0058"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Feliciano</surname>
<given-names>ND</given-names></string-name>, <string-name><surname>Ribeiro</surname>
<given-names>VS</given-names></string-name>, <string-name><surname>Gonzaga</surname>
<given-names>HT</given-names></string-name>, et al. <article-title>Short epitope-based synthetic peptides for serodiagnosis of human strongyloidiasis</article-title>. <source><italic toggle="yes">Immunol Lett</italic></source>. <year>2016</year>;<volume>172</volume>:<fpage>89</fpage>&#x02013;<lpage>93</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.imlet.2016.03.002</pub-id><pub-id pub-id-type="pmid">26956434</pub-id></mixed-citation></ref><ref id="cit0059"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Lindquist</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Marks</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Kleba</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Sthens</surname>
<given-names>RS</given-names></string-name>. <article-title>Phage-display antibody detection of Chlamydia trachomatis-associated antigens</article-title>. <source><italic toggle="yes">Microbiology</italic></source>. <year>2002</year>;<volume>148</volume>(<issue>Pt 2</issue>):<fpage>443</fpage>&#x02013;<lpage>451</lpage>. doi:<pub-id pub-id-type="doi">10.1099/00221287-148-2-443</pub-id><pub-id pub-id-type="pmid">11832508</pub-id></mixed-citation></ref><ref id="cit0060"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Franco</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Rocha</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Cox</surname>
<given-names>LJ</given-names></string-name>, et al. <article-title>Multi-Epitope Protein as a Tool of Serological Diagnostic Development for HTLV-1 and HTLV-2 Infections</article-title>. <source><italic toggle="yes">Front Public Health</italic></source>. <year>2022</year>;<volume>10</volume>:<fpage>884701</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpubh.2022.884701</pub-id><pub-id pub-id-type="pmid">35677763</pub-id></mixed-citation></ref><ref id="cit0061"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Murthy</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Guentzel</surname>
<given-names>MN</given-names></string-name>, et al. <article-title>Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection</article-title>. <source><italic toggle="yes">J Immunol</italic></source>. <year>2008</year>;<volume>180</volume>(<issue>5</issue>):<fpage>3375</fpage>&#x02013;<lpage>3382</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.180.5.3375</pub-id><pub-id pub-id-type="pmid">18292563</pub-id></mixed-citation></ref></ref-list></back></article>
